Study to Evaluate Sodium Stibogluconate With Interferon Alpha-2b

This study has been withdrawn prior to enrollment.
(Pharmaceutical sponsor terminated study.)
Sponsor:
Collaborator:
VioQuest Pharmaceuticals
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT01479309
First received: November 21, 2011
Last updated: November 23, 2011
Last verified: November 2011
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: February 2010
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)